| (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|
| Turnover | 89.57%684.59M | --370.6M | 32.81%199.62M | -10.13%361.13M | --150.3M | -23.83%401.84M | --527.54M |
| Operating income | 89.57%684.59M | 370.6M | 32.81%199.62M | -10.13%361.13M | 150.3M | -23.83%401.84M | 527.54M |
| Cost of sales | -90.79%-477.77M | ---253.24M | -45.07%-138.56M | -14.68%-250.42M | ---95.51M | 25.98%-218.37M | ---295M |
| Operating expenses | -90.79%-477.77M | -253.24M | -45.07%-138.56M | -14.68%-250.42M | -95.51M | 25.98%-218.37M | -295M |
| Gross profit | 86.81%206.82M | 117.36M | 11.44%61.06M | -39.66%110.72M | 54.79M | -21.10%183.48M | 232.55M |
| Selling expenses | -37.45%-73.63M | ---46.8M | -21.93%-27.78M | -29.24%-53.57M | ---22.78M | -75.82%-41.45M | ---23.57M |
| Administrative expenses | 47.66%-596.06M | ---379.31M | -33.92%-278.94M | -82.10%-1.14B | ---208.29M | -163.61%-625.37M | ---237.24M |
| Research and development expenses | -25.73%-1.37B | ---961M | -24.64%-644.64M | -3.11%-1.09B | ---517.21M | -39.53%-1.06B | ---758.57M |
| Impairment and provision | 42.00%-16.63M | ---5.54M | 79.14%-2.8M | 28.73%-28.66M | ---13.42M | -243.85%-40.22M | ---11.7M |
| -Other impairment is provision | 42.00%-16.63M | ---5.54M | 79.14%-2.8M | 28.73%-28.66M | ---13.42M | -243.85%-40.22M | ---11.7M |
| Special items of operating profit | -70.21%4.91M | --5.71M | -61.95%3.02M | 4.70%16.49M | --7.94M | -18.38%15.75M | --19.3M |
| Operating profit | 15.49%-1.85B | -1.27B | -27.34%-890.08M | -39.52%-2.19B | -698.98M | -100.99%-1.57B | -779.23M |
| Financing income | -2.60%172.31M | --126.43M | -16.07%74.95M | 33.97%176.9M | --89.29M | 265.66%132.04M | --36.11M |
| Financing cost | -164.50%-9.13M | ---7.27M | -142.77%-3.29M | 1.12%-3.45M | ---1.36M | 16.94%-3.49M | ---4.2M |
| Special items of earning before tax | 106.57%32.79M | --55.07M | 110.70%28.78M | 1.84%-499.21M | ---269.06M | 7.73%-508.59M | ---551.18M |
| Earning before tax | 34.26%-1.65B | -1.1B | 10.28%-789.64M | -29.02%-2.51B | -880.11M | -49.88%-1.95B | -1.3B |
| Tax | 30.13%-4.1M | ---3.41M | -17.98%-1.88M | -104.75%-5.87M | ---1.59M | ---2.87M | ---- |
| After-tax profit from continuing operations | 34.25%-1.65B | -1.1B | 10.23%-791.52M | -29.13%-2.52B | -881.7M | -50.10%-1.95B | -1.3B |
| Earning after tax | 34.25%-1.65B | -1.1B | 10.23%-791.52M | -29.13%-2.52B | -881.7M | -50.10%-1.95B | -1.3B |
| Profit attributable to shareholders | 34.25%-1.65B | -1.1B | 10.23%-791.52M | -29.13%-2.52B | -881.7M | -50.10%-1.95B | -1.3B |
| Basic earnings per share | 79.04%-1.79 | -1.21 | 88.21%-0.87 | 49.35%-8.54 | -7.38 | -52.17%-16.86 | -11.08 |
| Diluted earnings per share | 79.04%-1.79 | -1.21 | 88.21%-0.87 | 49.35%-8.54 | -7.38 | -52.17%-16.86 | -11.08 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | -- | -- | KPMG | -- | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.